This Nuclear Stock Could Be Your Ticket to Millionaire Status -- and It Didn't Even Need to Build a Reactor First
Key PointsMany advanced nuclear reactors require high-assay low-enriched uranium.
Growth investors have been flocking to advanced nuclear reactor companies such as NuScale Power and Oklo, recognizing the potential in these stocks during the ongoing nuclear renaissance. However, many have been hesitant to invest due to significant risks, including regulatory uncertainty and unguaranteed profits. There's an underappreciated nuclear stock that offers a strong wealth-building opportunity, requiring no reactor construction.
The specialized fuel for small modular reactors (SMRs) is high-assay low-enriched uranium (HALEU). Among the few companies producing HALEU, Centrus Energy (LEU -0.22%) stands out, branding itself as the sole HALEU enricher in the Western World with a first-mover advantage. Centrus boasts a $4.5 billion backlog of LEU and HALEU sales commitments, indicating robust demand as SMR makers acquire licenses and begin operations.
With a $2.4 billion market cap, Centrus stock could potentially tenfold to over $20 billion, turning a $10,000 investment into a millionaire's fortune.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
